'Business as usual' makes a big difference
Carolyn Compton, president and chief executive of the Critical Path Institute, isn't persuaded that her pro bono counsel at Paul Hastings appreciates their value. C-Path, as it is known, is attempting to streamline the development process for pharmaceuticals, medical devices and diagnostic methods to provide the developing world with lifesaving therapies. Paul Hastings, she said, has become its de facto general counsel.
This content has been archived. It is available exclusively through our partner LexisNexis®.
To view this content, please continue to LexisAdvance®.
Not a LexisAdvance® Subscriber? Subscribe Now
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
For questions call 1-877-256-2472 or contact us at email@example.com